Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 58

1.

A Novel Chromosomal Translocation Identified due to Complex Genetic Instability in iPSC Generated for Choroideremia.

Erkilic N, Gatinois V, Torriano S, Bouret P, Sanjurjo-Soriano C, Luca V, Damodar K, Cereso N, Puechberty J, Sanchez-Alcudia R, Hamel CP, Ayuso C, Meunier I, Pellestor F, Kalatzis V.

Cells. 2019 Sep 11;8(9). pii: E1068. doi: 10.3390/cells8091068.

2.

Generation of a human iPSC line, INMi004-A, with a point mutation in CRX associated with autosomal dominant Leber congenital amaurosis.

Erkilic N, Sanjurjo-Soriano C, Manes G, Dubois G, Hamel CP, Meunier I, Kalatzis V.

Stem Cell Res. 2019 Jul;38:101476. doi: 10.1016/j.scr.2019.101476. Epub 2019 Jun 3.

3.

Generation of a human iPSC line, INMi003-A, with a missense mutation in CRX associated with autosomal dominant cone-rod dystrophy.

Erkilic N, Sanjurjo-Soriano C, Diakatou M, Manes G, Dubois G, Hamel CP, Meunier I, Kalatzis V.

Stem Cell Res. 2019 Jul;38:101478. doi: 10.1016/j.scr.2019.101478. Epub 2019 Jun 7.

4.

Genome Editing as a Treatment for the Most Prevalent Causative Genes of Autosomal Dominant Retinitis Pigmentosa.

Diakatou M, Manes G, Bocquet B, Meunier I, Kalatzis V.

Int J Mol Sci. 2019 May 23;20(10). pii: E2542. doi: 10.3390/ijms20102542. Review.

5.

Nonsense-mediated mRNA decay efficiency varies in choroideremia providing a target to boost small molecule therapeutics.

Sarkar H, Mitsios A, Smart M, Skinner J, Welch AA, Kalatzis V, Coffey PJ, Dubis AM, Webster AR, Moosajee M.

Hum Mol Genet. 2019 Jun 1;28(11):1865-1871. doi: 10.1093/hmg/ddz028.

6.

Zika virus induces strong inflammatory responses and impairs homeostasis and function of the human retinal pigment epithelium.

Simonin Y, Erkilic N, Damodar K, Clé M, Desmetz C, Bolloré K, Taleb M, Torriano S, Barthelemy J, Dubois G, Lajoix AD, Foulongne V, Tuaillon E, Van de Perre P, Kalatzis V, Salinas S.

EBioMedicine. 2019 Jan;39:315-331. doi: 10.1016/j.ebiom.2018.12.010. Epub 2018 Dec 20.

7.

Generation of a human iPSC line, INMi002-A, carrying the most prevalent USH2A variant associated with Usher syndrome type 2.

Sanjurjo-Soriano C, Erkilic N, Manes G, Dubois G, Hamel CP, Meunier I, Kalatzis V.

Stem Cell Res. 2018 Dec;33:247-250. doi: 10.1016/j.scr.2018.11.007. Epub 2018 Nov 16.

8.

Generation of an iPSC line, INMi001-A, carrying the two most common USH2A mutations from a compound heterozygote with non-syndromic retinitis pigmentosa.

Sanjurjo-Soriano C, Erkilic N, Manes G, Dubois G, Hamel CP, Meunier I, Kalatzis V.

Stem Cell Res. 2018 Dec;33:228-232. doi: 10.1016/j.scr.2018.11.004. Epub 2018 Nov 10.

9.

Correction for Salinas et al., "Zika Virus Efficiently Replicates in Human Retinal Epithelium and Disturbs Its Permeability".

Salinas S, Erkilic N, Damodar K, Molès JP, Fournier-Wirth C, Van de Perre P, Kalatzis V, Simonin Y.

J Virol. 2018 Nov 12;92(23). pii: e01546-18. doi: 10.1128/JVI.01546-18. Print 2018 Dec 1. No abstract available.

10.

Lysosomal and network alterations in human mucopolysaccharidosis type VII iPSC-derived neurons.

Bayó-Puxan N, Terrasso AP, Creyssels S, Simão D, Begon-Pescia C, Lavigne M, Salinas S, Bernex F, Bosch A, Kalatzis V, Levade T, Cuervo AM, Lory P, Consiglio A, Brito C, Kremer EJ.

Sci Rep. 2018 Nov 9;8(1):16644. doi: 10.1038/s41598-018-34523-3.

11.

Pathogenicity of novel atypical variants leading to choroideremia as determined by functional analyses.

Vaché C, Torriano S, Faugère V, Erkilic N, Baux D, Garcia-Garcia G, Hamel CP, Meunier I, Zanlonghi X, Koenig M, Kalatzis V, Roux AF.

Hum Mutat. 2019 Jan;40(1):31-35. doi: 10.1002/humu.23671. Epub 2018 Nov 8.

PMID:
30341801
12.

Exogenous LRRK2G2019S induces parkinsonian-like pathology in a nonhuman primate.

Mestre-Francés N, Serratrice N, Gennetier A, Devau G, Cobo S, Trouche SG, Fontès P, Zussy C, De Deurwaerdere P, Salinas S, Mennechet FJ, Dusonchet J, Schneider BL, Saggio I, Kalatzis V, Luquin-Piudo MR, Verdier JM, Kremer EJ.

JCI Insight. 2018 Jul 26;3(14). pii: 98202. doi: 10.1172/jci.insight.98202. eCollection 2018 Jul 26.

13.

Guiding Lights in Genome Editing for Inherited Retinal Disorders: Implications for Gene and Cell Therapy.

Sanjurjo-Soriano C, Kalatzis V.

Neural Plast. 2018 May 8;2018:5056279. doi: 10.1155/2018/5056279. eCollection 2018. Review.

14.

The effect of PTC124 on choroideremia fibroblasts and iPSC-derived RPE raises considerations for therapy.

Torriano S, Erkilic N, Baux D, Cereso N, De Luca V, Meunier I, Moosajee M, Roux AF, Hamel CP, Kalatzis V.

Sci Rep. 2018 May 29;8(1):8234. doi: 10.1038/s41598-018-26481-7.

15.

Dietary, environmental, and genetic risk factors of Extensive Macular Atrophy with Pseudodrusen, a severe bilateral macular atrophy of middle-aged patients.

Douillard A, Picot MC, Delcourt C, Defoort-Dhellemmes S, Marzouka NA, Lacroux A, Zanlonghi X, Drumare I, Jozefowicz E, Bocquet B, Baudoin C, Perez-Roustit S, Arsène S, Gissot V, Devin F, Arndt C, Wolff B, Mauget-Faÿsse M, Quaranta M, Mura T, Deplanque D, Oubraham H, Cohen SY, Gastaud P, Zambrowski O, Creuzot-Garcher C, Saïd SM, Sahel JA, Souied E, Milazzo S, Garavito RB, Kalatzis V, Puech B, Hamel C, Audo I, Meunier I.

Sci Rep. 2018 May 1;8(1):6840. doi: 10.1038/s41598-018-25003-9.

16.

Pathogenicity of a novel missense variant associated with choroideremia and its impact on gene replacement therapy.

Torriano S, Erkilic N, Faugère V, Damodar K, Hamel CP, Roux AF, Kalatzis V.

Hum Mol Genet. 2017 Sep 15;26(18):3573-3584. doi: 10.1093/hmg/ddx244.

PMID:
28911202
17.

Zika Virus Efficiently Replicates in Human Retinal Epithelium and Disturbs Its Permeability.

Salinas S, Erkilic N, Damodar K, Molès JP, Fournier-Wirth C, Van de Perre P, Kalatzis V, Simonin Y.

J Virol. 2017 Jan 18;91(3). pii: e02144-16. doi: 10.1128/JVI.02144-16. Print 2017 Feb 1. No abstract available. Erratum in: J Virol. 2018 Nov 12;92(23):.

18.

Functional rescue of REP1 following treatment with PTC124 and novel derivative PTC-414 in human choroideremia fibroblasts and the nonsense-mediated zebrafish model.

Moosajee M, Tracey-White D, Smart M, Weetall M, Torriano S, Kalatzis V, da Cruz L, Coffey P, Webster AR, Welch E.

Hum Mol Genet. 2016 Aug 15;25(16):3416-3431. doi: 10.1093/hmg/ddw184. Epub 2016 Jun 21.

PMID:
27329764
19.

A Comprehensive Analysis of Choroideremia: From Genetic Characterization to Clinical Practice.

Sanchez-Alcudia R, Garcia-Hoyos M, Lopez-Martinez MA, Sanchez-Bolivar N, Zurita O, Gimenez A, Villaverde C, Rodrigues-Jacy da Silva L, Corton M, Perez-Carro R, Torriano S, Kalatzis V, Rivolta C, Avila-Fernandez A, Lorda I, Trujillo-Tiebas MJ, Garcia-Sandoval B, Lopez-Molina MI, Blanco-Kelly F, Riveiro-Alvarez R, Ayuso C.

PLoS One. 2016 Apr 12;11(4):e0151943. doi: 10.1371/journal.pone.0151943. eCollection 2016.

20.

Clinical Evaluation and Cone Alterations in Choroideremia.

Nabholz N, Lorenzini MC, Bocquet B, Lacroux A, Faugère V, Roux AF, Kalatzis V, Meunier I, Hamel CP.

Ophthalmology. 2016 Aug;123(8):1830-1832. doi: 10.1016/j.ophtha.2016.02.025. Epub 2016 Mar 15. No abstract available.

PMID:
26992839
21.

Cultured Cells from the Human Oocyte Cumulus Niche Are Efficient Feeders to Propagate Pluripotent Stem Cells.

Assou S, Pourret E, Péquignot M, Rigau V, Kalatzis V, Aït-Ahmed O, Hamamah S.

Stem Cells Dev. 2015 Oct 1;24(19):2317-27. doi: 10.1089/scd.2015.0043. Epub 2015 Jul 8.

22.

Successful Living-Related Renal Allograft in a Recipient With Factor V Leiden Deficiency: A Case Report.

Florou E, Koukoulaki M, Theodoros T, Kalatzis V, Vougas V, Stamataki E, Kokkinou VC, Kostakis A, Drakopoulos S.

Exp Clin Transplant. 2017 Feb;15(1):96-99. doi: 10.6002/ect.2014.0255. Epub 2015 Jun 15.

23.

Splenic inflammatory pseudotumor-like follicular dendritic cell tumor.

Vardas K, Manganas D, Papadimitriou G, Kalatzis V, Kyriakopoulos G, Chantziara M, Exarhos D, Drakopoulos S.

Case Rep Oncol. 2014 Jun 27;7(2):410-6. doi: 10.1159/000365000. eCollection 2014 May.

24.

Acute prostatitis caused by Raoultella planticola in a renal transplant recipient: a novel case.

Koukoulaki M, Bakalis A, Kalatzis V, Belesiotou E, Papastamopoulos V, Skoutelis A, Drakopoulos S.

Transpl Infect Dis. 2014 Jun;16(3):461-4. doi: 10.1111/tid.12213. Epub 2014 Apr 21.

PMID:
24750300
25.

Corrective GUSB transfer to the canine mucopolysaccharidosis VII cornea using a helper-dependent canine adenovirus vector.

Serratrice N, Cubizolle A, Ibanes S, Mestre-Francés N, Bayo-Puxan N, Creyssels S, Gennetier A, Bernex F, Verdier JM, Haskins ME, Couderc G, Malecaze F, Kalatzis V, Kremer EJ.

J Control Release. 2014 May 10;181:22-31. doi: 10.1016/j.jconrel.2014.02.022. Epub 2014 Mar 4.

26.

Proof of concept for AAV2/5-mediated gene therapy in iPSC-derived retinal pigment epithelium of a choroideremia patient.

Cereso N, Pequignot MO, Robert L, Becker F, De Luca V, Nabholz N, Rigau V, De Vos J, Hamel CP, Kalatzis V.

Mol Ther Methods Clin Dev. 2014 Apr 2;1:14011. doi: 10.1038/mtm.2014.11. eCollection 2014.

27.

Corrective GUSB transfer to the canine mucopolysaccharidosis VII brain.

Cubizolle A, Serratrice N, Skander N, Colle MA, Ibanes S, Gennetier A, Bayo-Puxan N, Mazouni K, Mennechet F, Joussemet B, Cherel Y, Lajat Y, Vite C, Bernex F, Kalatzis V, Haskins ME, Kremer EJ.

Mol Ther. 2014 Apr;22(4):762-73. doi: 10.1038/mt.2013.283. Epub 2013 Dec 17.

28.

Choroideremia: towards a therapy.

Kalatzis V, Hamel CP, MacDonald IM; First International Choroideremia Research Symposium.

Am J Ophthalmol. 2013 Sep;156(3):433-437.e3. doi: 10.1016/j.ajo.2013.05.009. Epub 2013 Jun 28.

PMID:
23810476
29.

Side scatter intensity is highly heterogeneous in undifferentiated pluripotent stem cells and predicts clonogenic self-renewal.

Ramirez JM, Bai Q, Péquignot M, Becker F, Kassambara A, Bouin A, Kalatzis V, Dijon-Grinand M, De Vos J.

Stem Cells Dev. 2013 Jun 15;22(12):1851-60. doi: 10.1089/scd.2012.0658. Epub 2013 Mar 5.

30.

Corneal transduction by intra-stromal injection of AAV vectors in vivo in the mouse and ex vivo in human explants.

Hippert C, Ibanes S, Serratrice N, Court F, Malecaze F, Kremer EJ, Kalatzis V.

PLoS One. 2012;7(4):e35318. doi: 10.1371/journal.pone.0035318. Epub 2012 Apr 16.

31.

Screening for a canine model of choroideremia exclusively identifies nonpathogenic CHM variants.

Robert L, Sénéchal A, Bocquet B, Herbin L, Chaudieu G, Kalatzis V, André C, Hamel CP.

Ophthalmic Res. 2011;45(3):155-63. doi: 10.1159/000313992. Epub 2010 Sep 23.

PMID:
20861657
32.

Renal phenotype of the cystinosis mouse model is dependent upon genetic background.

Nevo N, Chol M, Bailleux A, Kalatzis V, Morisset L, Devuyst O, Gubler MC, Antignac C.

Nephrol Dial Transplant. 2010 Apr;25(4):1059-66. doi: 10.1093/ndt/gfp553. Epub 2009 Oct 21.

PMID:
19846395
33.

The cell adhesion molecule "CAR" and sialic acid on human erythrocytes influence adenovirus in vivo biodistribution.

Seiradake E, Henaff D, Wodrich H, Billet O, Perreau M, Hippert C, Mennechet F, Schoehn G, Lortat-Jacob H, Dreja H, Ibanes S, Kalatzis V, Wang JP, Finberg RW, Cusack S, Kremer EJ.

PLoS Pathog. 2009 Jan;5(1):e1000277. doi: 10.1371/journal.ppat.1000277. Epub 2009 Jan 2.

34.

Gene transfer may be preventive but not curative for a lysosomal transport disorder.

Hippert C, Dubois G, Morin C, Disson O, Ibanes S, Jacquet C, Schwendener R, Antignac C, Kremer EJ, Kalatzis V.

Mol Ther. 2008 Aug;16(8):1372-81. doi: 10.1038/mt.2008.126. Epub 2008 Jun 24.

35.

Cystine accumulation in the CNS results in severe age-related memory deficits.

Maurice T, Hippert C, Serratrice N, Dubois G, Jacquet C, Antignac C, Kremer EJ, Kalatzis V.

Neurobiol Aging. 2009 Jun;30(6):987-1000. Epub 2007 Oct 30.

PMID:
17977621
36.

The ocular anomalies in a cystinosis animal model mimic disease pathogenesis.

Kalatzis V, Serratrice N, Hippert C, Payet O, Arndt C, Cazevieille C, Maurice T, Hamel C, Malecaze F, Antignac C, Müller A, Kremer EJ.

Pediatr Res. 2007 Aug;62(2):156-62. Erratum in: Pediatr Res. 2007 Nov;62(5):558.

PMID:
17597652
37.

Molecular pathogenesis of cystinosis: effect of CTNS mutations on the transport activity and subcellular localization of cystinosin.

Kalatzis V, Nevo N, Cherqui S, Gasnier B, Antignac C.

Hum Mol Genet. 2004 Jul 1;13(13):1361-71. Epub 2004 May 5.

PMID:
15128704
38.

New aspects of the pathogenesis of cystinosis.

Kalatzis V, Antignac C.

Pediatr Nephrol. 2003 Mar;18(3):207-15. Epub 2003 Feb 27. Review.

PMID:
12644911
39.

Identification of 14 novel CTNS mutations and characterization of seven splice site mutations associated with cystinosis.

Kalatzis V, Cohen-Solal L, Cordier B, Frishberg Y, Kemper M, Nuutinen EM, Legrand E, Cochat P, Antignac C.

Hum Mutat. 2002 Dec;20(6):439-46.

PMID:
12442267
40.

Cystinosis: from gene to disease.

Kalatzis V, Antignac C.

Nephrol Dial Transplant. 2002 Nov;17(11):1883-6. Review. No abstract available.

PMID:
12401840
41.

Intralysosomal cystine accumulation in mice lacking cystinosin, the protein defective in cystinosis.

Cherqui S, Sevin C, Hamard G, Kalatzis V, Sich M, Pequignot MO, Gogat K, Abitbol M, Broyer M, Gubler MC, Antignac C.

Mol Cell Biol. 2002 Nov;22(21):7622-32.

42.

Immunolocalization of cystinosin, the protein defective in cystinosis.

Haq MR, Kalatzis V, Gubler MC, Town MM, Antignac C, Van't Hoff WG, Woolf AS.

J Am Soc Nephrol. 2002 Aug;13(8):2046-51.

43.

Cystinosin, the protein defective in cystinosis, is a H(+)-driven lysosomal cystine transporter.

Kalatzis V, Cherqui S, Antignac C, Gasnier B.

EMBO J. 2001 Nov 1;20(21):5940-9.

44.

Characterization of a putative founder mutation that accounts for the high incidence of cystinosis in Brittany.

Kalatzis V, Cherqui S, Jean G, Cordier B, Cochat P, Broyer M, Antignac C.

J Am Soc Nephrol. 2001 Oct;12(10):2170-4.

45.

The targeting of cystinosin to the lysosomal membrane requires a tyrosine-based signal and a novel sorting motif.

Cherqui S, Kalatzis V, Trugnan G, Antignac C.

J Biol Chem. 2001 Apr 20;276(16):13314-21. Epub 2001 Jan 9.

46.

Identification and characterisation of the murine homologue of the gene responsible for cystinosis, Ctns.

Cherqui S, Kalatzis V, Forestier L, Poras I, Antignac C.

BMC Genomics. 2000;1:2. Epub 2000 Dec 6.

47.

Branchio-Oto-Renal syndrome.

Kalatzis V, Petit C.

Adv Otorhinolaryngol. 2000;56:39-44. Review. No abstract available.

PMID:
10868212
48.

Branchio-otic syndromes imbroglio.

Kalatzis V, Petit C.

Am J Med Genet. 1999 Feb 19;82(5):440-1. No abstract available.

PMID:
10069718
49.

Molecular approach to the pathogenesis of renal anomalies in Kallmann's syndrome and in the branchio-oto-renal syndrome.

Hardelin JP, Soussi-Yanicostas N, Levilliers J, Kalatzis V, Abdelhak S, Cohen-Salmon M, Petit C.

Adv Nephrol Necker Hosp. 1998;28:419-28. Review. No abstract available.

PMID:
9890002
50.

Supplemental Content

Loading ...
Support Center